In Stock Recombinant Mouse Lrig1 Protein (his Tag) Best Choice [wud3sQCT]

In Stock Recombinant Mouse Lrig1 Protein (his Tag) Best Choice [wud3sQCT]: A Potent Tool for Research

Introducing the In Stock Recombinant Mouse Lrig1 Protein (his Tag) Best Choice [wud3sQCT], a cutting-edge research tool designed to facilitate studies in tumor biology and receptor tyrosine kinase regulation. This protein is synthesized using HEK293 cells, ensuring high purity and reliability for your experiments. With its unique C-His tag and molecular weight of 84.5 kDa, the Recombinant Mouse LRIG1 Protein offers exceptional versatility for a wide range of applications.

• Enhance your research with high-quality recombinant proteins.
• Facilitate studies on tumor suppressor and receptor tyrosine kinase regulation.

Product Properties and Specifications

The In Stock Recombinant Mouse Lrig1 Protein (his Tag) Best Choice [wud3sQCT] is highly pure, with a purity level exceeding 95% as determined by reducing SDS-PAGE. It is also endotoxin-free, ensuring minimal interference in your experiments. This protein is lyophilized for long-term stability and ease of use, with storage recommendations provided for optimal shelf life. Key specifications include an observed molecular weight of 94 kDa and a calculated molecular weight of 84.5 kDa.

• High purity for reliable research outcomes.
• Endotoxin-free to minimize interference.

Applications and Benefits

The In Stock Recombinant Mouse Lrig1 Protein (his Tag) Best Choice [wud3sQCT] is an essential tool for researchers studying tumor suppressors and receptor tyrosine kinases. Its ability to inhibit the growth of different types of malignancies makes it particularly valuable for cancer research. This protein is also ideal for investigating the role of LRIG1 in epidermal growth factor signaling, making it a versatile choice for various experimental setups. Ideal for researchers in oncology, molecular biology, and cellular biology, the Recombinant Mouse LRIG1 Protein offers numerous benefits:

• Contribute to advancements in cancer research.
• Explore the role of LRIG1 in epidermal growth factor signaling.